Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
Glycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to inter...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Platelets |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09537104.2024.2315037 |
_version_ | 1826930387461341184 |
---|---|
author | Longqiang Shu Shanyi Lin Shumin Zhou Ting Yuan |
author_facet | Longqiang Shu Shanyi Lin Shumin Zhou Ting Yuan |
author_sort | Longqiang Shu |
collection | DOAJ |
description | Glycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to interact with platelets. As platelets have many opportunities to engage circulating tumor cells, they represent an important avenue into understanding the role glycosylation plays in tumor metastasis. Platelet involvement in tumor metastasis is evidenced by observations that platelets protect tumor cells from damaging shear forces and immune system attack, aid metastasis through the endothelium at specific sites, and facilitate tumor survival and colonization. During platelet-tumor-cell interactions, many opportunities for glycan-ligand binding emerge. This review integrates the latest information about glycans, their ligands, and how they mediate platelet-tumor interactions. We also discuss adaptive changes that tumors undergo upon glycan-lectin binding and the impact glycans have on targeted therapeutic strategies for treating tumors in clinical settings. |
first_indexed | 2024-03-07T23:44:56Z |
format | Article |
id | doaj.art-333f592f2f27485ea5acd73f4f5b397f |
institution | Directory Open Access Journal |
issn | 0953-7104 1369-1635 |
language | English |
last_indexed | 2025-02-17T16:26:50Z |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Platelets |
spelling | doaj.art-333f592f2f27485ea5acd73f4f5b397f2024-12-17T06:39:35ZengTaylor & Francis GroupPlatelets0953-71041369-16352024-12-0135110.1080/09537104.2024.2315037Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasisLongqiang Shu0Shanyi Lin1Shumin Zhou2Ting Yuan3Department of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Microsurgery on Extremities, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaGlycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to interact with platelets. As platelets have many opportunities to engage circulating tumor cells, they represent an important avenue into understanding the role glycosylation plays in tumor metastasis. Platelet involvement in tumor metastasis is evidenced by observations that platelets protect tumor cells from damaging shear forces and immune system attack, aid metastasis through the endothelium at specific sites, and facilitate tumor survival and colonization. During platelet-tumor-cell interactions, many opportunities for glycan-ligand binding emerge. This review integrates the latest information about glycans, their ligands, and how they mediate platelet-tumor interactions. We also discuss adaptive changes that tumors undergo upon glycan-lectin binding and the impact glycans have on targeted therapeutic strategies for treating tumors in clinical settings.https://www.tandfonline.com/doi/10.1080/09537104.2024.2315037Cancer metastasisglycoconjugationsglycosylationlectinplatelets |
spellingShingle | Longqiang Shu Shanyi Lin Shumin Zhou Ting Yuan Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis Platelets Cancer metastasis glycoconjugations glycosylation lectin platelets |
title | Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis |
title_full | Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis |
title_fullStr | Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis |
title_full_unstemmed | Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis |
title_short | Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis |
title_sort | glycan lectin interactions between platelets and tumor cells drive hematogenous metastasis |
topic | Cancer metastasis glycoconjugations glycosylation lectin platelets |
url | https://www.tandfonline.com/doi/10.1080/09537104.2024.2315037 |
work_keys_str_mv | AT longqiangshu glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis AT shanyilin glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis AT shuminzhou glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis AT tingyuan glycanlectininteractionsbetweenplateletsandtumorcellsdrivehematogenousmetastasis |